BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 26490434)

  • 41. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
    Farge D; Debourdeau P; Beckers M; Baglin C; Bauersachs RM; Brenner B; Brilhante D; Falanga A; Gerotzafias GT; Haim N; Kakkar AK; Khorana AA; Lecumberri R; Mandala M; Marty M; Monreal M; Mousa SA; Noble S; Pabinger I; Prandoni P; Prins MH; Qari MH; Streiff MB; Syrigos K; Bounameaux H; Büller HR
    J Thromb Haemost; 2013 Jan; 11(1):56-70. PubMed ID: 23217107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation.
    Pandor A; Horner D; Davis S; Goodacre S; Stevens JW; Clowes M; Hunt BJ; Nokes T; Keenan J; de Wit K
    Health Technol Assess; 2019 Dec; 23(63):1-190. PubMed ID: 31851608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A modified video-feedback intervention for carers of foster children aged 6 years and under with reactive attachment disorder: a feasibility study and pilot RCT.
    Oliveira P; Stevens E; Barge L; Comyn J; Langley K; Ramchandani P; Wright B; Woolgar M; Kennedy E; Byford S; Shearer J; Scott S; Barlow J; Glaser D; Senior R; Fonagy P; Fearon P
    Health Technol Assess; 2022 Aug; 26(35):1-106. PubMed ID: 35959710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.
    Deerhake JP; Merz JC; Cooper JV; Eagle KA; Fay WP
    J Thromb Thrombolysis; 2007 Apr; 23(2):107-13. PubMed ID: 17221327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Graduated Compression Stockings as an Adjunct to Low Dose Low Molecular Weight Heparin in Venous Thromboembolism Prevention in Surgery: A Multicentre Randomised Controlled Trial.
    Shalhoub J; Norrie J; Baker C; Bradbury AW; Dhillon K; Everington T; Gohel MS; Hamady Z; Heatley F; Hudson J; Hunt BJ; Lawton R; Stansby G; Stephens-Boal A; Toh S; Warwick D; Davies AH;
    Eur J Vasc Endovasc Surg; 2017 Jun; 53(6):880-885. PubMed ID: 28396238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retrograde intramedullary nail fixation compared with fixed-angle plate fixation for fracture of the distal femur: the TrAFFix feasibility RCT.
    Griffin XL; Costa ML; Phelps E; Parsons N; Dritsaki M; Png ME; Achten J; Tutton E; Lerner R; McGibbon A; Baird J
    Health Technol Assess; 2019 Sep; 23(51):1-132. PubMed ID: 31549959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guided self-help for depression in autistic adults: the ADEPT feasibility RCT.
    Russell A; Gaunt D; Cooper K; Horwood J; Barton S; Ensum I; Ingham B; Parr J; Metcalfe C; Rai D; Kessler D; Wiles N
    Health Technol Assess; 2019 Dec; 23(68):1-94. PubMed ID: 31856942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.
    Al-Hameed F; Al-Dorzi HM; AlMomen A; Algahtani F; AlZahrani H; AlSaleh K; AlSheef M; Owaidah T; Alhazzani W; Neumann I; Wiercioch W; Brozek J; Schünemann H; Akl EA
    Ann Saudi Med; 2015; 35(2):95-106. PubMed ID: 26336014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD004318. PubMed ID: 30481366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-molecular-weight heparin to prevent postpartum venous thromboembolism. A pilot randomised placebo-controlled trial.
    Rodger MA; Phillips P; Kahn SR; James AH; Konkle BA;
    Thromb Haemost; 2015 Jan; 113(1):212-6. PubMed ID: 25373438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A group memory rehabilitation programme for people with traumatic brain injuries: the ReMemBrIn RCT.
    das Nair R; Bradshaw LE; Carpenter H; Clarke S; Day F; Drummond A; Fitzsimmons D; Harris S; Montgomery AA; Newby G; Sackley C; Lincoln NB
    Health Technol Assess; 2019 Apr; 23(16):1-194. PubMed ID: 31032782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.
    Campbell IA; Bentley DP; Prescott RJ; Routledge PA; Shetty HG; Williamson IJ
    BMJ; 2007 Mar; 334(7595):674. PubMed ID: 17289685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial.
    Fowler RA; Mittmann N; Geerts WH; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
    Trials; 2014 Dec; 15():502. PubMed ID: 25528663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
    Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
    Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis.
    van Rein N; Biedermann JS; van der Meer FJM; Cannegieter SC; Wiersma N; Vermaas HW; Reitsma PH; Kruip MJHA; Lijfering WM
    J Thromb Haemost; 2017 Jul; 15(7):1386-1391. PubMed ID: 28440008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different temperature thresholds for antipyretic intervention in critically ill children with fever due to infection: the FEVER feasibility RCT.
    Peters MJ; Khan I; Woolfall K; Deja E; Mouncey PR; Wulff J; Mason A; Agbeko R; Draper ES; Fenn B; Gould DW; Koelewyn A; Klein N; Mackerness C; Martin S; O'Neill L; Ramnarayan P; Tibby S; Tume L; Watkins J; Thorburn K; Wellman P; Harrison DA; Rowan KM
    Health Technol Assess; 2019 Feb; 23(5):1-148. PubMed ID: 30793698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticoagulation for perioperative thromboprophylaxis in people with cancer.
    Matar CF; Kahale LA; Hakoum MB; Tsolakian IG; Etxeandia-Ikobaltzeta I; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009447. PubMed ID: 29993117
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.